InvestSMART

Racura Oncology Ltd (ASX: RAC) - Announcements

Current share price for RAC : $1.995 0.015 (0.75%)+

ASX company news and announcements for Racura Oncology Ltd (RAC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Racura Oncology Ltd (RAC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Racura Oncology Ltd (RAC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Racura Oncology Ltd (RAC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$391 Appendix 3Y - Dr Daniel Tillett 25 Nov 2025 4:53PM $2.910 $1.995 fallen by 31.44%
$391 Appendix 3Y - Dr Peter Smith 25 Nov 2025 4:51PM $2.910 $1.995 fallen by 31.44%
$391 Notification regarding unquoted securities - RAC 25 Nov 2025 4:51PM $2.910 $1.995 fallen by 31.44%
$391 Cleansing Notice 25 Nov 2025 4:30PM $2.910 $1.995 fallen by 31.44%
$391 Application for quotation of securities - RAC 25 Nov 2025 4:28PM $2.910 $1.995 fallen by 31.44%
$391 Replacement Constitution 24 Nov 2025 2:56PM $2.960 $1.995 fallen by 32.60%
$391 Results of Annual General Meeting 24 Nov 2025 2:54PM $2.960 $1.995 fallen by 32.60%
$391 Race Oncology 2025 Chairs Address and AGM Presentation 24 Nov 2025 10:20AM $3.000 $1.995 fallen by 33.50%
$391 Application for quotation of securities - RAC 20 Nov 2025 3:33PM $2.985 $1.995 fallen by 33.17%
$391 Notification of cessation of securities - RAC 20 Nov 2025 9:41AM $3.040 $1.995 fallen by 34.38%
$391 Race Clinical Program Update 17 Nov 2025 9:11AM $3.280 $1.995 fallen by 39.18%
$391 Application for quotation of securities - RAC 13 Nov 2025 12:38PM $3.330 $1.995 fallen by 40.09%
$391 Application for quotation of securities - RAC 6 Nov 2025 4:34PM $3.190 $1.995 fallen by 37.46%
$391 September 2025 Quarterly Activity Report and Appendix 4C 31 Oct 2025 9:06AM $3.500 $1.995 fallen by 43%
$391 Application for quotation of securities - RAC 30 Oct 2025 2:42PM $3.450 $1.995 fallen by 42.17%
$391 Revised Trading Policy 23 Oct 2025 5:43PM $3.740 $1.995 fallen by 46.66%
$391 Application for quotation of securities - RAC 23 Oct 2025 2:02PM $3.800 $1.995 fallen by 47.50%
$391 Letter to Shareholders, Notice of AGM & Proxy Form 22 Oct 2025 11:58AM $3.760 $1.995 fallen by 46.94%
$391 Race Presents Mechanism of Action Data at ESMO 2025 20 Oct 2025 8:58AM $4.250 $1.995 fallen by 53.06%
$391 Race Oncology letter regarding exercise of options 17 Oct 2025 11:29AM $4.100 $1.995 fallen by 51.34%
$391 Application for quotation of securities - RAC 16 Oct 2025 4:13PM $4.180 $1.995 fallen by 52.27%
$391 Application for quotation of securities - RAC 9 Oct 2025 4:28PM $4.690 $1.995 fallen by 57.46%
$391 International G4 Expert Laurence Hurley Joins Race SAB 9 Oct 2025 9:05AM $4.220 $1.995 fallen by 52.73%
$391 Race Anticancer MOA Webinar 8 Oct 2025 4:16PM $4.220 $1.995 fallen by 52.73%
$391 Race Online Investor Briefing Invitation 6 Oct 2025 2:56PM $3.850 $1.995 fallen by 48.18%

101 - 125 of 988 results

Page 5 of 40

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.